We are live on ! Find out more

37 hedge funds and large institutions have $4.14M invested in Imunon in 2021 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 12 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

554% more call options, than puts

Call options by funds: $85K | Put options by funds: $13K

20% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 5

0% more funds holding

Funds holding: 37 → 37 (0)

1.8% less ownership

Funds ownership: 10.67% → 8.87% (-1.8%)

57% less capital inflows, than outflows

Capital inflows: $859K | Capital outflows: $1.99M

67% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 12

Holders
37
Holders Change
–
Holders Change %
0%
% of All Funds
0.57%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
4
Reduced
12
Closed
5
Calls
$85​K
Puts
$13​K
Net Calls
+$72​K
Net Calls Change
-⁠$47​K

IMNN Hedge Fund Activity: Q4 2021 in Review

37 of the 6,524 institutional investors tracked by Wall St. Rank reported a position in Imunon (IMNN) for Q4 2021, worth a combined $4.14M — down 51% from $8.54M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new IMNN positions and 5 closed out — a net gain of 1 holder — while 4 added to existing stakes and 12 trimmed.

The largest buyer was Two Sigma Advisers, adding an estimated $267K. The largest seller was Morgan Stanley, cutting an estimated $1.83M.

  • 37 institutional investors held Imunon (IMNN) as of Q4 2021, unchanged from Q3 2021.
  • Funds reported $4.14M of Imunon stock for Q4 2021, down 51% quarter-over-quarter.
  • 6 funds opened new Imunon positions in Q4 2021 and 5 closed out, a net change of +1 holder.
  • The largest Imunon buyer in Q4 2021 was Two Sigma Advisers, an estimated $267K added.
  • The largest Imunon seller in Q4 2021 was Morgan Stanley, an estimated $1.83M sold.

Based on aggregated 13F filings for Q4 2021.